GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of telehealth — my 11-week log, condensed into one table — 30 comments in the full submission. View in context.
567
c/compounding·submitted 9 months ago by u/elin_ferrari

telehealth — my 11-week log, condensed into one table

Regulatorybranch of 13 comments

Genuinely asking, not being difficult. Everyone in c/glp1canada repeats that state board is important. I believe it, but I have never seen anyone show why, and when I search I get 19 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true…

Read the full submission and all 30 comments →

This branch

13 comments, started 9 months ago
u/stubborn_batchlist_pls-38 points·9 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/rafael_ostergaard1 point·9 months ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
u/elin_ferrariOP-45 points·9 months ago

The telehealth + compounding combo cost 503A plus 21% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/enzo_ferrari1 point·9 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
u/elin_ferrari0 points·9 months ago

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
u/marit_mwangi1 point·9 months ago

API source questions are on-topic and compounders dodging them is newsworthy

replysharereportpermalink
u/elin_ferrariOP1 point·9 months ago

The telehealth + compounding combo cost 503B plus 7% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/elin_ferrariOP1 point·9 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/joaquin_trevino1 point·9 months ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/discount_math_dm1 point·9 months ago

API transparency is the question that separates good compounders from sketchy ones

Yes, exactly this, and it is the bit that took me 92 weeks to accept.

replysharereportpermalink
u/honest_syringe1 point·9 months ago

state board rules differ, say which state

replysharereportpermalink
u/lukas_vermeulen1 point·9 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/sofia_danquah1 point·9 months ago

shortage list status is telehealth, check the actual list

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.